EXOGEN reduces treatment costs associated with certain fractures.

From a study published in the Bulletin for NYU Hospital for Joint Diseases24

Learn more

Help reduce healthcare costs with EXOGEN

Demonstrated to help speed bone healing time, the EXOGEN Ultrasound Bone Healing System treats indicated* fresh and non-union* fractures in just 20 minutes a day. The FDA-approved device uses painless, low-intensity, pulsed ultrasound technology to help accelerate broken bone recovery at each stage of the natural repair process.3 If broken bone recovery happens faster, workers can get back on the job and patients may avoid additional fracture surgeries,1 which can help reduce healthcare costs.

EXOGEN has been shown to heal 86% of non-unions,* which may help patients avoid additional fracture surgeries.1

Go >

Clinical studies show EXOGEN may speed bone healing of indicated* fresh fractures by 38%.2,12

Go >

EXOGEN works in just 20 minutes a day. The short treatment time may help increase compliance.

Go >
find your managed care rep

Want to talk with an EXOGEN managed care expert? Or learn about earning CEUs through Bioventus? Contact your managed care representative here.

Physicians, contact your sales representative here.

contact us

Call our customer service specialists at (800) 396-4325 or contact us on the web today.


Find out how EXOGEN could help you reduce healthcare costs in our just-the-facts white paper.

Browse more resources


*Summary of Indications for Use: The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established non-unions excluding skull and vertebra.

In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopaedically managed by closed reduction and cast immobilization.

There are no known contraindications for the EXOGEN device. Safety and effectiveness has not been established for individuals lacking skeletal maturity; pregnant or nursing women; patients with cardiac pacemakers; on fractures due to bone cancer; or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel. Full prescribing information can be found here or by contacting customer service at 800-396-4325.

A non-union is considered to be established when the fracture site shows no visibly progressive signs of healing.

© 2014 Bioventus LLC
EXOGEN is a registered trademark of Bioventus LLC.
Bioventus and the Bioventus logo are trademarks of Bioventus LLC.

If you are a payer in , your managed care rep is:


Physicians, contact your sales representative here.